. . . stocks . . . . . http://lm360.us/Oquenda-neighbour-of-Massi-from-Michala?Needhamfa=212 eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention. . james taylor exclusive: 'i could see my heart stretching my skin. i thought i was going to die' . . .the latest figures mean that since january 2000, scottish widows has paid a total of £2.5bn in claims to more than 86,000 customers. . .